MP Advisors

62 result(s)
  • Clear Filters
  • Sort By:
  • Results per page:
Categories
Published Date

Price



Publishing Partners

The rapid growth of the generic industry has come with a number of challenges, such as heavy competition, including from authorized generics...

$4,000.00

The U.S. psoriasis treatment market for Biologics and Biosimilars was estimated at $6.6bn in 2016 is projected to almost double during the f...

$4,000.00

The U.S. psoriasis treatment market for Biologics and Biosimilars was estimated at $6.6bn in 2016 is projected to almost double during the f...

$4,000.00

Xtandi – Replacing competitor from Zytiga to Casodex (Bicalutamide) for a bigger pie in Prostate cancer & Finding its niche in crowded BC ...

$4,500.00

Xtandi – Replacing competitor from Zytiga to Casodex (Bicalutamide) for a bigger pie in Prostate cancer & Finding its niche in crowded BC m...

$4,500.00

Major pharma companies are continue to improve the productivity by taking different approaches like focusing on selected therapy area and ma...

$2,000.00
Ask Our Analyst
Press Release Notification
Follow US
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.